US Stock MarketDetailed Quotes

CRH CRH PLC

Watchlist

77.200
-0.430-0.55%

Close Apr 25 16:00 ET

77.980
+0.780+1.01%

Post 17:49 ET

53.02BMarket Cap17.83P/E (TTM)

CRH PLC Stock Forum

Moomoo AI

Mar 9 21:53

CRH's dividend is seen as sustainable, backed by profit and cash flow. Its growing earnings and low payout ratios hint at a promising long-term dividend stock. The firm's consistent dividend and earnings growth show a commitment to rewarding shareholders.

CRH (NYSE:CRH) Could Be A Buy For Its Upcoming Dividend

Moomoo AI

Feb 29 20:47

Despite lower than expected Q4 numbers, investors are not worried due to the company's positive outlook for 2024, driven by significant infrastructure investment and re-industrialization activity across key markets in North America and Europe.

CRH Stock Is Up. Earnings Missed but U.S. Construction Is Strong. -- Barrons.com

Moomoo AI

Jan 23 21:37

The strong EPS growth and insider buying at CRH indicate a positive outlook for the company. The growth rate and insider activity suggest that the company could be a good investment opportunity.

Do CRH's (NYSE:CRH) Earnings Warrant Your Attention?

Moomoo AI

Dec 23, 2023 00:16

The market's view of CRH has improved over the last five years, likely due to consistent earnings growth. Recent insider buying and strong share price momentum suggest potential investment opportunities.

CRH (NYSE:CRH) Shareholders Have Earned a 24% CAGR Over the Last Five Years

Explore moomoo's "Insider Activity" for institutional sentiment

Moomoo AI

Dec 9, 2023 20:31

CRH's dividend is sustainable unless earnings drop sharply, as it's backed by profit and cash flow. A low payout ratio and quick earnings per share growth hint a focus on reinvestment. Over the past decade, dividends increased by around 5.2% annually, less than earnings per share growth. CRH's business growth prospects suggest enticing future dividends.

CRH Plc (NYSE:CRH) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Moomoo AI

Nov 30, 2023 21:13

CRH plc is seen as undervalued, with its positive outlook and expected earnings growth hinting at a good time for shareholders to accumulate more holdings. The current share price may not fully mirror the promising future, presenting a potential buying opportunity for investors.

Why CRH Plc (NYSE:CRH) Could Be Worth Watching

Mooers Radar

Dec 12, 2022 17:10

ColumnsUS Top Gap Ups and Downs on 12/9: DOCU, NFLX, AVGO, LULU and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $Korea Electric Power(KEP.US)$ - up 7.39%
2. $DocuSign(DOCU.US)$ - up 5.58%
3. $InterContinental Hotels(IHG.US)$ - up 3%
4. $Woori Financial(WF.US)$ - up 2.78%
5. $KB Financial(KB.US)$ - up 2.34%
6. $Netflix(NFLX.US)$ - up 2.28%
7. $Shinhan Financial Group Co Ltd(SHG.US)$...

+21

iamiam

May 4, 2022 13:34

UPDATE May 4

Even from work I could tell that was a wild day.
I wish I could've been posting updates at open as my buy calls

had a decent day

Iam going to do things differently again. I'll chart QQQ first on a short time frame to highlight how money moves.
Then the Dollar, 10yr Treasury, Gold, VIX, and Oil to show 3 possible outcomes from tomorrow's FED meeting. The charts have a lot of triangles ready to break. I'll end by charting futures of Oil, Silver, VIX, and NQ
$Invesco QQQ Trust(QQQ.US)$ The volu...

+11

Moomoo Breakfast US

Apr 19, 2022 20:40

ColumnsToday's pre-market stock movers: PLUG, CMPI, JNJ, LMT and more

Gainers:
• $Checkmate Pharmaceuticals(CMPI.US)$ +331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash)
• $Axsome Therapeutics(AXSM.US)$ +27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder)
• $Super Micro Computer(SMCI.US)$ +14.3% (earnings report)
• $Plug Power(PLUG.US)$ +9.24% (t...

Analysts Notebook

Mar 22, 2022 19:31

ColumnsTop upgrades and downgrades on 3/22

Upgrades
• $Cronos Group(CRON.US)$ : Barclays Upgrades to Equal Weight from Underweight - PT $5 (from $5.50)
• $Ecolab(ECL.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $196 (from $210)
• $Helios Technologies(HLIO.US)$ : Stifel Upgrades to Buy From Hold - PT $95 (from $85)
• $Manhattan Associates(MANH.US)$ : Raymond James Upgrades to Outperform From Market Perform - PT $170
• $Altria(MO.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $57
• $Procter & Gamble(PG.US)$ : Truist ...

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall